march 19 tirzepatide Everyone's picking a side. 💛🆚💙 Let the Phase III data settle it. vs SEMAGLUTIDE The most important head-to-head in metabolic medicine right now. Swipe through all 9 slides 👉 ━━━━━━━━━━━━━━━━━━━━━ 🔬 trim Dose or concentration:2.4 mg Pharmacokinetics, Safety and Tolerability

march 19 tirzepatide Everyone's picking a side. 💛🆚💙 Let the Phase III data settle it. vs SEMAGLUTIDE The most important head-to-head in metabolic medicine right now. Swipe through all 9 slides 👉 ━━━━━━━━━━━━━━━━━━━━━ 🔬 trim Dose or concentration:2.4 mg Pharmacokinetics, Safety and Tolerability

Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial | Advances in Therapy | Springer Nature Link

Only about 10% to 15% of patients in major trials lost less than 5% of their weight (Yale Medicine)

trim

Dose or concentration:2.4 mg

Semaglutide and tirzepatide weight loss benefits were compared in people with Type 2 diabetes